基于HMMR在肺腺癌组织中表达水平及其对LUAD患者预后影响的生物信息学分析

doi:10.13481/j.1671-587X.20210621

Abstract

Abstract: Objective

To investigate the expression of hyaluronan-mediated motility receptor （HMMR） in the lung adenocarcinoma （LUAD） tissue and its impact on the prognosis of the LUAD patients， and to elucidate the role of HMMR in the occurrence and development of LUAD.

Methods

The expression levels HMMR mRNA and protein in the LUAD tissue were assessed by Gene Expression Omnibus （GEO）， the Cancer Genome Atlas （TCGA） and Human Protein Atlas （HPA）. The effect of HMMR expression on the overall survival （OS） and disease-free survival （DFS） of the LUAD patients was analyzed by using the GEPIA2 database. The relationships between HMMR mRNA expression and the clinicopathological parameters and prognosis of the LUAD patients were analyzed by using the TCGA database. The GSEA enrichment analysis was used to explore the pathways significantly enriched for HMMR in the LUAD tissue. The relationship between HMMR mRNA expression and TP53 gene mutations was probed by using the UALCAN database， and the interaction between HMMR and the proteins in the p53 signaling pathway was predicted by the Search Tool for Recurring Instances of Neighbouring Genes （STRING） database.

Results

The expression levels of HMMR mRNA and protein in LUAD tissue were significantly higher than those in normal and adjacent tissues （P<0.01）. The patients with higher HMMR mRNA expression had shorter OS and DFS（P<0.01）. In LUAD tissue， the HMMR mRNA expression was associated with the patients’ TNM stage，T stage， and N stage （P<0.01）.The univariate and multivariate Cox analysis results showed that the OS of the patients with high HMMR mRNA expression was shorter. The GSEA enrichment analysis results showed that cell cycle， homologous recombination， p53 signaling pathway， bladder cancer， pancreatic cancer， small cell lung cancer， and ubiquitin-mediated proteolysis pathways were significantly enriched in the high expression phenotype of HMMR.

Conclusion

The expression of HMMR in LUAD tissue is significantly up-regulated，and the highly expressed HMMR mRNA is an independent evaluation indicator of poor prognosis in the LUAD patients.

Key words: lung adenocarcinoma, hyaluronan-mediated motility receptor, database, prognosis

CLC Number:

R734.2

Shuzhen LI,Yajie CAO,Haiying GENG,Zengxiaorui CAI,Chunmei DAI,Youfeng WEN,Ning LI. Bioinformatics analysis based on expression level of HMMR in lung adenocarcinoma tissue and its impact on prognosis of LUAD patients[J].Journal of Jilin University(Medicine Edition), 2021, 47(6): 1502-1509.

Figures/Tables 9

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Tab. 1

Tab. 2

Fig. 6

Fig. 7

References 29

1	CHEN R， MANOCHAKIAN R， JAMES L， et al. Emerging therapeutic agents for advanced non-small cell lung cancer［J］. J Hematol Oncol， 2020， 13（1）： 58.
2	XU J Y， ZHANG C， WANG X，et al.Integrative proteomic characterization of human lung adenocarcinoma［J］. Cell， 2020， 182（1）： 245-261.e17.
3	HE Z C， MEI L， CONNELL M， et al. Hyaluronan mediated motility receptor （HMMR） encodes an evolutionarily conserved homeostasis， mitosis， and meiosis regulator rather than a hyaluronan receptor［J］. Cells， 2020， 9（4）： 819.
4	TOLG C， LIU M， COUSTEILS K， et al. Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization［J］. J Biol Chem， 2020， 295（16）： 5427-5448.
5	MISRA S， HASCALL V C， MARKWALD R R，et al. Interactions between hyaluronan and its receptors （CD44， RHAMM） regulate the activities of inflammation and cancer［J］. Front Immunol， 2015， 6： 201.
6	CHEN F， ZHU X Q， ZHENG J， et al. RHAMM regulates the growth and migration of lung adenocarcinoma A549 cell line by regulating Cdc2/CyclinB1 and MMP9 genes Running title： RHAMM regulates the growth of lung adenocarcinoma cells［J］. Math Biosci Eng， 2020， 17（3）： 2150-2163.
7	LI W， PAN T H， JIANG W， et al. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma［J］. Biomed Pharmacother， 2020， 129： 110217.
8	AUGUSTIN F， FIEGL M， SCHMID T， et al. Receptor for hyaluronic acid-mediated motility （RHAMM， CD168） expression is prognostically important in both nodal negative and nodal positive large cell lung cancer［J］. J Clin Pathol， 2015， 68（5）： 368-373.
9	BARRETT T， WILHITE S E， LEDOUX P， et al. NCBI GEO： archive for functional genomics data sets： update［J］. Nucleic Acids Res， 2013， 41（database issue）： D991-D995.
10	WANG Z， JENSEN M A， ZENKLUSEN J C. A practical guide to the cancer genome atlas （TCGA）［J］. Methods Mol Biol， 2016， 1418： 111-141.
11	SUN S S， FU Y， LIN J Y. Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma［J］. Oncol Lett， 2020， 19（4）： 2765-2772.
12	XIA Z， OU-YANG W， HU T， et al. Prognostic significance of CDC25C in lung adenocarcinoma： an analysis of TCGA data［J］. Cancer Genet， 2019（233/234）： 67-74.
13	WU H R， ZHANG J. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis： a study based on TCGA data［J］. Gynecol Oncol， 2018， 149（3）： 592-597.
14	LI C W， TANG Z F， ZHANG W J， et al. GEPIA2021： integrating multiple deconvolution-based analysis into GEPIA［J］. Nucleic Acids Res， 2021， 49（W1）： W242-W246.
15	CHANDRASHEKAR D S， BASHEL B， BALASUBRAMANYA S A H， et al. UALCAN： a portal for facilitating tumor subgroup gene expression and survival analyses［J］. Neoplasia， 2017， 19（8）： 649-658.
16	CONNELL M， CHEN H， JIANG J， et al. HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development ［J］. Elife， 2017， 6： e28672.
17	MAXWELL C A， RASMUSSEN E， ZHAN F， et al. RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma［J］. Blood， 2004， 104（4）： 1151-1158.
18	HAMILTON S R， FARD S F， PAIWAND F F， et al. The hyaluronan receptors CD44 and Rhamm （CD168） form complexes with ERK1， 2 that sustain high basal motility in breast cancer cells［J］. J Biol Chem， 2007， 282（22）： 16667-16680.
19	CHU T L H， CONNELL M， ZHOU L， et al. Cell cycle-dependent tumor engraftment and migration are enabled by aurora-A［J］. Mol Cancer Res， 2018， 16（1）： 16-31.
20	TILGHMAN J， WU H， SANG Y， et al. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells［J］. Cancer Res， 2014， 74（11）： 3168-3179.
21	ASSMANN V， MARSHALL J F， FIEBER C， et al. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells［J］. J Cell Sci， 1998， 111（12）： 1685-1694.
22	GREINER J， RINGHOFFER M， TANIGUCHI M， et al. Receptor for hyaluronan acid-mediated motility （RHAMM） is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia［J］. Exp Hematol， 2002， 30（9）： 1029-1035.
23	LI H， GUO L， LI J W， et al. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers： relevance with tumor progression［J］. Int J Oncol， 2000， 17（5）： 927-932.
24	CHOI S， WANG D， CHEN X， et al. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression［J］. Mol Cancer， 2019， 18（1）： 92.
25	ZHANG D Y， LIU J H， XIE T， et al. Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma［J］. Int J Biol Sci， 2020， 16（15）： 2812-2827.
26	WANG D， NARULA N， AZZOPARDI S， et al. Expression of the receptor for hyaluronic acid mediated motility （RHAMM） is associated with poor prognosis and metastasis in non-small cell lung carcinoma［J］. Oncotarget， 2016， 7（26）： 39957-39969.
27	MARKASZ L， SAVANI R C， SEDIN G， et al. The receptor for hyaluronan-mediated motility （RHAMM） expression in neonatal bronchiolar epithelium correlates negatively with lung air content［J］. Early Hum Dev， 2018， 127： 58-68.
28	SONG J M， IM J， NHO R S， et al. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells［J］. Mol Carcinog， 2019， 58（3）： 321-333.
29	YANG D， MA Y， ZHAO P， et al. Systematic screening of protein-coding gene expression identified HMMR as a potential independent indicator of unfavorable survival in patients with papillary muscle-invasive bladder cancer［J］. Biomed Pharmacother， 2019， 120： 109433.

[1]	Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745.
[2]	Limei WEN,Yali GUO,Wenmei MA,Taotao XUE,Ruoyu GENG,Chong MA,Xinhong ZHANG,Jianhua YANG. Bioinformatic analysis of TCGA database based on INPP4B gene expression in hepatocellular carcinoma and its experimental validation [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1618-1629.
[3]	Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX₂ NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266.
[4]	Ming CHEN,Qinghua LUO,Hongguang JIN,Liang HAN. Atypical lipomatous tumor of left lower limb: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1384-1389.
[5]	Ziru ZHOU,Mengfei SUN,Huakun ZHANG,Shuyan SUN,Qi SUN,Feng LI,Yunzhao CHEN,Jie YU,Yuwen CAO,Xiaobin CUI. Expression of Rh family C glycoprotein in esophageal squamous carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1019-1027.
[6]	Changyu SHI,Yong LI,Jing DENG,Chunmei PIAO,Ming JIN. Bioinformatics analysis on adjustment effect of colorectal liver metastases model in mice based on complement alternative pathway and its experimental verification [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 703-715.
[7]	Fan WANG,Xin WEN,Yixuan WANG,Yuan WANG. Effect of gap junction β2 on prognosis of patients with lung adenocarcinoma and biological behavior of lung adenocarcinoma A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 716-726.
[8]	Xialing HUANG,Dandan ZHANG,Xuemei ZHANG. Analysis on relationship between methylation of MSX1 gene and clinical pathological features and prognosis of patients with cervical cancer [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 749-756.
[9]	Xiaoyan WANG,Xuelian LI,Bin LIANG,Wenfei TIAN,Hailin MA,Zhijing MO. Analysis on relationship between CALU and prognosis of hepatocellular carcinoma patients and its mechanism based on transcriptome and single cell sequencing data [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 447-459.
[10]	Yu SHI,Jingzhi LI,Hongqiang CHEN,Shimeng ZHOU,Na WANG,Jia CAO,Li YIN,Wenbin LIU. Bioinformatics analysis and experimental validation of BPS and BPF on signaling pathways of male reproductive system damage [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 460-470.
[11]	Haiying GENG,Yan YU,Chunmei DAI,Youfeng WEN,Ning LI. Expression of TRIM24 protein in human clear cell renal cell carcinoma tissue and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 486-492.
[12]	Xiao SUN,Yini WANG,Fangsheng GAO,Ying ZHANG,Ping LIN. Characteristics of intestinal flora in patients with depression based on GMrepo database and correlation analysis between depression and intestinal flora [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 157-163.
[13]	Xi YANG,Qin YUAN,Lan YANG,Wenjie ZHANG. Bioinformatics analysis on PDE1B expression and prognosis of gastric cancer and tumor microenvironment [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1664-1676.
[14]	Jiaxin YI,Yangyu ZHANG,Yingli FU,Yuchen PAN,Yongjie HAN,Jing JIANG,Yanhua WU. Effect of MEIS1 expression on survival in patients after radical gastrectomy and its value in prognostic evaluation [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1358-1364.
[15]	Chaojie GUO,Jiajia ZHANG,Jie ZENG,Huiyu WANG, AIERFATI·Aimaier,Jiang XU. Expressions of PLOD1 in oral squamous cell carcinoma tissue and cells and their significances [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1035-1043.

Bioinformatics analysis based on expression level of HMMR in lung adenocarcinoma tissue and its impact on prognosis of LUAD patients

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References 29

Related Articles 15

Metrics

Comments

Recommended 10